(Salem, OR) -- Drug maker Glenmark has settled a lawsuit with Oregon and several other states. The suit alleged Glenmark inflated prices and limited competition by colluding with other pharmaceutical companies. Under the nearly 30-million-dollar settlement, Glenmark also agreed to help with ongoing legal action against 33 corporate defendants and 25 individual executives. Oregon receives 316-thousand-dollars from the settlement. Customers who bought drugs from Glenmark, Lannett, Bausch, Apotex or Heritage from May 2009 through December 2019 may be eligible for compensation.